Screener

Eligibility screening

Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities

Sponsored by Eli Lilly and CompanyStudy detailsClinicalTrials.gov

15 US sites in CA, CT, GA, IL +8

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.